再生医療の世界市場（～2026年）

• 英文タイトル：Global Regenerative Therapies Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04479 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は再生医療のグローバル市場について調査・分析したレポートです。種類別（同種移植片、異種移植片、同種移植片）市場規模、用途別（軟部組織修復、心臓血管、歯科、整形外科、中枢神経系疾患治療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別再生医療の競争状況、市場シェア ・世界の再生医療市場：種類別市場規模 2015年-2020年（同種移植片、異種移植片、同種移植片） ・世界の再生医療市場：種類別市場規模予測 2021年-2026年（同種移植片、異種移植片、同種移植片） ・世界の再生医療市場：用途別市場規模 2015年-2020年（軟部組織修復、心臓血管、歯科、整形外科、中枢神経系疾患治療、その他） ・世界の再生医療市場：用途別市場規模予測 2021年-2026年（軟部組織修復、心臓血管、歯科、整形外科、中枢神経系疾患治療、その他） ・北米の再生医療市場分析：米国、カナダ ・ヨーロッパの再生医療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの再生医療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の再生医療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの再生医療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acelity、Mesoblast、Nuo Therapeutics、Astellas Pharma、Organovo、Orgenesis、Sanofi、Athersys、Takeda、Cytori Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Regeneration is renewal through the internal processes of a body or system. Something which embodies this action can be described as regenerative.
The global market study on regenerative therapies is expected to grow rapidly owing to its wide applications in orthopedic, cardiovascular and soft tissue repair.

Market Analysis and Insights: Global Regenerative Therapies Market
The global Regenerative Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Regenerative Therapies Scope and Market Size
Regenerative Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Acelity
Mesoblast
Nuo Therapeutics
Astellas Pharma
Organovo
Orgenesis
Sanofi
Athersys
Takeda
Cytori Therapeutics

Market segment by Type, the product can be split into
Allografts
Xenografts
Alloplasts
Market segment by Application, split into
Soft Tissue Repair
Cardiovascular
Dental
Orthopaedic
CNS Disease Treatment
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Regenerative Therapies Revenue
1.4 Market by Type
1.4.1 Global Regenerative Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allografts
1.4.3 Xenografts
1.4.4 Alloplasts
1.5 Market by Application
1.5.1 Global Regenerative Therapies Market Share by Application: 2020 VS 2026
1.5.2 Soft Tissue Repair
1.5.3 Cardiovascular
1.5.4 Dental
1.5.5 Orthopaedic
1.5.6 CNS Disease Treatment
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Regenerative Therapies Market Perspective (2015-2026)
2.2 Global Regenerative Therapies Growth Trends by Regions
2.2.1 Regenerative Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Regenerative Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Regenerative Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Regenerative Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Regenerative Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Regenerative Therapies Players by Market Size
3.1.1 Global Top Regenerative Therapies Players by Revenue (2015-2020)
3.1.2 Global Regenerative Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Regenerative Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Regenerative Therapies Market Concentration Ratio
3.2.1 Global Regenerative Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Regenerative Therapies Revenue in 2019
3.3 Regenerative Therapies Key Players Head office and Area Served
3.4 Key Players Regenerative Therapies Product Solution and Service
3.5 Date of Enter into Regenerative Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Regenerative Therapies Historic Market Size by Type (2015-2020)
4.2 Global Regenerative Therapies Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Regenerative Therapies Market Size by Application (2015-2020)
5.2 Global Regenerative Therapies Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Regenerative Therapies Market Size (2015-2020)
6.2 Regenerative Therapies Key Players in North America (2019-2020)
6.3 North America Regenerative Therapies Market Size by Type (2015-2020)
6.4 North America Regenerative Therapies Market Size by Application (2015-2020)

7 Europe
7.1 Europe Regenerative Therapies Market Size (2015-2020)
7.2 Regenerative Therapies Key Players in Europe (2019-2020)
7.3 Europe Regenerative Therapies Market Size by Type (2015-2020)
7.4 Europe Regenerative Therapies Market Size by Application (2015-2020)

8 China
8.1 China Regenerative Therapies Market Size (2015-2020)
8.2 Regenerative Therapies Key Players in China (2019-2020)
8.3 China Regenerative Therapies Market Size by Type (2015-2020)
8.4 China Regenerative Therapies Market Size by Application (2015-2020)

9 Japan
9.1 Japan Regenerative Therapies Market Size (2015-2020)
9.2 Regenerative Therapies Key Players in Japan (2019-2020)
9.3 Japan Regenerative Therapies Market Size by Type (2015-2020)
9.4 Japan Regenerative Therapies Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Regenerative Therapies Market Size (2015-2020)
10.2 Regenerative Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Regenerative Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Regenerative Therapies Market Size by Application (2015-2020)

11 India
11.1 India Regenerative Therapies Market Size (2015-2020)
11.2 Regenerative Therapies Key Players in India (2019-2020)
11.3 India Regenerative Therapies Market Size by Type (2015-2020)
11.4 India Regenerative Therapies Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Regenerative Therapies Market Size (2015-2020)
12.2 Regenerative Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Regenerative Therapies Market Size by Type (2015-2020)
12.4 Central & South America Regenerative Therapies Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Acelity
13.1.1 Acelity Company Details
13.1.2 Acelity Business Overview
13.1.3 Acelity Regenerative Therapies Introduction
13.1.4 Acelity Revenue in Regenerative Therapies Business (2015-2020))
13.1.5 Acelity Recent Development
13.2 Mesoblast
13.2.1 Mesoblast Company Details
13.2.2 Mesoblast Business Overview
13.2.3 Mesoblast Regenerative Therapies Introduction
13.2.4 Mesoblast Revenue in Regenerative Therapies Business (2015-2020)
13.2.5 Mesoblast Recent Development
13.3 Nuo Therapeutics
13.3.1 Nuo Therapeutics Company Details
13.3.2 Nuo Therapeutics Business Overview
13.3.3 Nuo Therapeutics Regenerative Therapies Introduction
13.3.4 Nuo Therapeutics Revenue in Regenerative Therapies Business (2015-2020)
13.3.5 Nuo Therapeutics Recent Development
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Details
13.4.2 Astellas Pharma Business Overview
13.4.3 Astellas Pharma Regenerative Therapies Introduction
13.4.4 Astellas Pharma Revenue in Regenerative Therapies Business (2015-2020)
13.4.5 Astellas Pharma Recent Development
13.5 Organovo
13.5.1 Organovo Company Details
13.5.2 Organovo Business Overview
13.5.3 Organovo Regenerative Therapies Introduction
13.5.4 Organovo Revenue in Regenerative Therapies Business (2015-2020)
13.5.5 Organovo Recent Development
13.6 Orgenesis
13.6.1 Orgenesis Company Details
13.6.2 Orgenesis Business Overview
13.6.3 Orgenesis Regenerative Therapies Introduction
13.6.4 Orgenesis Revenue in Regenerative Therapies Business (2015-2020)
13.6.5 Orgenesis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Regenerative Therapies Introduction
13.7.4 Sanofi Revenue in Regenerative Therapies Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Athersys
13.8.1 Athersys Company Details
13.8.2 Athersys Business Overview
13.8.3 Athersys Regenerative Therapies Introduction
13.8.4 Athersys Revenue in Regenerative Therapies Business (2015-2020)
13.8.5 Athersys Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Regenerative Therapies Introduction
13.9.4 Takeda Revenue in Regenerative Therapies Business (2015-2020)
13.9.5 Takeda Recent Development
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Details
13.10.2 Cytori Therapeutics Business Overview
13.10.3 Cytori Therapeutics Regenerative Therapies Introduction
13.10.4 Cytori Therapeutics Revenue in Regenerative Therapies Business (2015-2020)
13.10.5 Cytori Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Regenerative Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Regenerative Therapies Revenue
Table 3. Ranking of Global Top Regenerative Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Regenerative Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Allografts
Table 6. Key Players of Xenografts
Table 7. Key Players of Alloplasts
Table 8. Global Regenerative Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Regenerative Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Regenerative Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Regenerative Therapies Market Share by Regions (2015-2020)
Table 12. Global Regenerative Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Regenerative Therapies Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Regenerative Therapies Market Growth Strategy
Table 18. Main Points Interviewed from Key Regenerative Therapies Players
Table 19. Global Regenerative Therapies Revenue by Players (2015-2020) (Million US$)
Table 20. Global Regenerative Therapies Market Share by Players (2015-2020)
Table 21. Global Top Regenerative Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies as of 2019)
Table 22. Global Regenerative Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Regenerative Therapies Product Solution and Service
Table 25. Date of Enter into Regenerative Therapies Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 28. Global Regenerative Therapies Market Size Share by Type (2015-2020)
Table 29. Global Regenerative Therapies Revenue Market Share by Type (2021-2026)
Table 30. Global Regenerative Therapies Market Size Share by Application (2015-2020)
Table 31. Global Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 32. Global Regenerative Therapies Market Size Share by Application (2021-2026)
Table 33. North America Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Regenerative Therapies Market Share (2019-2020)
Table 35. North America Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 36. North America Regenerative Therapies Market Share by Type (2015-2020)
Table 37. North America Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 38. North America Regenerative Therapies Market Share by Application (2015-2020)
Table 39. Europe Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Regenerative Therapies Market Share (2019-2020)
Table 41. Europe Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Regenerative Therapies Market Share by Type (2015-2020)
Table 43. Europe Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Regenerative Therapies Market Share by Application (2015-2020)
Table 45. China Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 46. China Key Players Regenerative Therapies Market Share (2019-2020)
Table 47. China Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 48. China Regenerative Therapies Market Share by Type (2015-2020)
Table 49. China Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 50. China Regenerative Therapies Market Share by Application (2015-2020)
Table 51. Japan Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Regenerative Therapies Market Share (2019-2020)
Table 53. Japan Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Regenerative Therapies Market Share by Type (2015-2020)
Table 55. Japan Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Regenerative Therapies Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Regenerative Therapies Market Share (2019-2020)
Table 59. Southeast Asia Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Regenerative Therapies Market Share by Type (2015-2020)
Table 61. Southeast Asia Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Regenerative Therapies Market Share by Application (2015-2020)
Table 63. India Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 64. India Key Players Regenerative Therapies Market Share (2019-2020)
Table 65. India Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 66. India Regenerative Therapies Market Share by Type (2015-2020)
Table 67. India Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 68. India Regenerative Therapies Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Regenerative Therapies Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Regenerative Therapies Market Share (2019-2020)
Table 71. Central & South America Regenerative Therapies Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Regenerative Therapies Market Share by Type (2015-2020)
Table 73. Central & South America Regenerative Therapies Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Regenerative Therapies Market Share by Application (2015-2020)
Table 75. Acelity Company Details
Table 76. Acelity Business Overview
Table 77. Acelity Product
Table 78. Acelity Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 79. Acelity Recent Development
Table 80. Mesoblast Company Details
Table 81. Mesoblast Business Overview
Table 82. Mesoblast Product
Table 83. Mesoblast Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 84. Mesoblast Recent Development
Table 85. Nuo Therapeutics Company Details
Table 86. Nuo Therapeutics Business Overview
Table 87. Nuo Therapeutics Product
Table 88. Nuo Therapeutics Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 89. Nuo Therapeutics Recent Development
Table 90. Astellas Pharma Company Details
Table 91. Astellas Pharma Business Overview
Table 92. Astellas Pharma Product
Table 93. Astellas Pharma Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 94. Astellas Pharma Recent Development
Table 95. Organovo Company Details
Table 96. Organovo Business Overview
Table 97. Organovo Product
Table 98. Organovo Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 99. Organovo Recent Development
Table 100. Orgenesis Company Details
Table 101. Orgenesis Business Overview
Table 102. Orgenesis Product
Table 103. Orgenesis Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 104. Orgenesis Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Product
Table 108. Sanofi Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 109. Sanofi Recent Development
Table 110. Athersys Business Overview
Table 111. Athersys Product
Table 112. Athersys Company Details
Table 113. Athersys Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 114. Athersys Recent Development
Table 115. Takeda Company Details
Table 116. Takeda Business Overview
Table 117. Takeda Product
Table 118. Takeda Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 119. Takeda Recent Development
Table 120. Cytori Therapeutics Company Details
Table 121. Cytori Therapeutics Business Overview
Table 122. Cytori Therapeutics Product
Table 123. Cytori Therapeutics Revenue in Regenerative Therapies Business (2015-2020) (Million US$)
Table 124. Cytori Therapeutics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Therapies Market Share by Type: 2020 VS 2026
Figure 2. Allografts Features
Figure 3. Xenografts Features
Figure 4. Alloplasts Features
Figure 5. Global Regenerative Therapies Market Share by Application: 2020 VS 2026
Figure 6. Soft Tissue Repair Case Studies
Figure 7. Cardiovascular Case Studies
Figure 8. Dental Case Studies
Figure 9. Orthopaedic Case Studies
Figure 10. CNS Disease Treatment Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Therapies Report Years Considered
Figure 13. Global Regenerative Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Regenerative Therapies Market Share by Regions: 2020 VS 2026
Figure 15. Global Regenerative Therapies Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Regenerative Therapies Market Share by Players in 2019
Figure 18. Global Top Regenerative Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Therapies Revenue in 2019
Figure 20. North America Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Regenerative Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

---